Beihai Gofar Chuanshan Biological Co., Ltd.
600538
Rank in Stocks
#14325
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries,... Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol disinfectant; honeysuckle mixture; feier syrup; medicinal wine for traumatic injury under the Hippocampus brand; and sea snake medicinal wine. In addition, the company offers forensic DNA testing equipment, reagents, and consumables; and technical services, including DNA testing services. Further, it engages in culture and arts activities. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.
Share Price
$0.63091973
Last synced: 2026-11-10
Market Cap
$330.73M
Change (1 day)
1.20%
Change (1 year)
-24.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Beihai Gofar Chuanshan Biological Co., Ltd. (600538)
Category
Healthcare
Operating Margin for Beihai Gofar Chuanshan Biological Co., Ltd. (600538)
Operating Margin as of November 2026 TTM: -6.82%
According to Beihai Gofar Chuanshan Biological Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -6.82%. At the end of 2025 the company had an operating margin of -9.63%.
Operating Margin history for Beihai Gofar Chuanshan Biological Co., Ltd. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -6.82% | -29.18% |
| 2025 | -9.63% | -64.24% |
| 2024 | -26.93% | 27.81% |
| 2023 | -21.07% | -329.02% |
| 2022 | 9.20% | 157.70% |
| 2021 | 3.57% | 8.18% |
| 2020 | 3.30% | -13.39% |
| 2019 | 3.81% | -141.32% |
| 2018 | -9.22% | 78.68% |
| 2017 | -5.16% | 4.03% |
| 2016 | -4.96% | -459.42% |
| 2015 | 1.38% | -110.01% |
| 2014 | -13.79% | 172.53% |
| 2013 | -5.06% | -50.97% |
| 2012 | -10.32% | 43.53% |
| 2011 | -7.19% | -58.34% |
| 2010 | -17.26% | -71.30% |
| 2009 | -60.13% | 16.94% |
| 2008 | -51.42% | -1,748.08% |
| 2007 | 3.12% | -204.00% |
| 2006 | -3.00% | -158.14% |
| 2005 | 5.16% | -23.10% |
| 2004 | 6.71% | -52.07% |
| 2003 | 14.00% | -42.15% |
| 2002 | 24.20% | -11.97% |
| 2001 | 27.49% | -6.66% |
| 2000 | 29.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -109.14% |
US
|
|
| 31.60% | -104.63% |
SE
|
|
| 30.13% | -104.42% |
FR
|
|
| 29.76% | -104.36% |
HK
|
|
| 30.46% | -104.47% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin
What is Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin?
Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin is -6.82%, as of Nov 2026.
What was Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin in 2025?
In 2025, Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin was -9.63%, compared with -26.93% in 2024.
How has Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin was highest in 2022 (9.20%) and lowest in 2024 (-26.93%).
How does Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin compare with similar companies?
Beihai Gofar Chuanshan Biological Co., Ltd.'s operating margin (-6.82%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.